Cabot president and CEO Patrick Prevost will take a medical leave of absence to recover from a minor stroke, the company says. Prevost expects to resume CEO duties in January.
An interim office of the CEO will take up CEO duties during Prevost’s absence. The office includes executive v.p. and CFO Eduardo Cordeiro, senior v.p. and general counsel Brian Berube, executive v.p. and president/reinforcement materials Sean Keohane, and executive v.p. and president/performance chemicals and specialty fluids Nicholas Cross. The CEO office will report to the board with oversight provided by non-executive chairman John O’Brien, Cabot said in a regulatory filing.
“Patrick has the full support of the board, and we wish him a speedy recovery,” O’Brien says. “While Patrick is recovering, I will be working closely with the CEO Office. I am confident that they will ensure the continued execution of the operational objectives that have been set for fiscal 2016 as well as the company’s strategic initiatives.”
Prevost, who was named Cabot CEO in 2008, intends to interact with the interim CEO office during his leave. “It is in Cabot’s best interest, and mine, that I focus on my health during my leave of absence,” Prevost said. “I look forward to fully re-engaging with the business in the near future.”
By Vincent Valk
Source: Chemical Week
BASF increased sales by €2.6 billion compared with the first quarter of 2020 to €19.4 billion. This was mainly due to higher prices and volume growth.
Air Products acquired General Electric’s gasification business in 2018 which included the 50% stake in a syngas joint venture with China Shenhua Coal to Liquid and Chemical, a subsidiary of China Energy Group.
Tove Andersen, currently EVP Yara Europe, has been appointed President and CEO of Tomra Systems ASA. She will take up the new position latest 1 November 2021.